Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic
Gespeichert in:
Veröffentlicht in: | Vaccine 2007, Vol.25 (31), p.5735-5744 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5744 |
---|---|
container_issue | 31 |
container_start_page | 5735 |
container_title | Vaccine |
container_volume | 25 |
creator | NELL, Patricia KOHL, Katrin S GRAHAM, Philip L LARUSSA, Philip S MARCY, S. Michael FULGINITI, Vincent A MARTIN, Bryan MCMAHON, Ann NORTON, Scott A TROLIN, Ingrid |
description | |
format | Article |
fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_18941324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18941324</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_189413243</originalsourceid><addsrcrecordid>eNqNUc1uEzEQXlCRCIV3mAtSkRyxm6SQ9gZNERwqIcGBWzWxZ3eNvLblsbfdPncfgElTCdITJ8vj79fzvJo164_L-eK0WR9Vs3rxYTVfNfWvl9Ur5t91XZ8um7PZs_vvKXSJmO1IMKLW1lsEZEAPaEZKTEAj-QxtcC7cWN8B3cbAJRHk8Jcy2lQYzuEChWGolWG2QUS8ga5YQ856YggtGMwIWtRI7xBKIOgmtqwewFHSiB8-sAVuh6F4e7e_M7aUp73EOXxOtuuzjHdquA3pEZRFB5Oxd2RAH-bhp4HakA6L8j9ND7xPJGfsJ4e3u6jkNcUenajy-0-byytJzxSz1TCQF_LuQUEr3K6QgiJm0aF4GuBiDHlJhbmHk823zY93ChJyryD3KQzboKccosigAk3OFbdXwy1r2ZUC603Zt1XAN4IQQ_V0GYe1FPRTDPJbVr-uXrTomN48nsfV2y-XPy--ziOyRtcm9NrydUx2wDRdN-uzVbNcrJb_i_sDRfHfig</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic</title><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>NELL, Patricia ; KOHL, Katrin S ; GRAHAM, Philip L ; LARUSSA, Philip S ; MARCY, S. Michael ; FULGINITI, Vincent A ; MARTIN, Bryan ; MCMAHON, Ann ; NORTON, Scott A ; TROLIN, Ingrid</creator><creatorcontrib>NELL, Patricia ; KOHL, Katrin S ; GRAHAM, Philip L ; LARUSSA, Philip S ; MARCY, S. Michael ; FULGINITI, Vincent A ; MARTIN, Bryan ; MCMAHON, Ann ; NORTON, Scott A ; TROLIN, Ingrid</creatorcontrib><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Applied microbiology ; Biological and medical sciences ; Fundamental and applied biological sciences. Psychology ; Microbiology ; Miscellaneous ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Virology</subject><ispartof>Vaccine, 2007, Vol.25 (31), p.5735-5744</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18941324$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>NELL, Patricia</creatorcontrib><creatorcontrib>KOHL, Katrin S</creatorcontrib><creatorcontrib>GRAHAM, Philip L</creatorcontrib><creatorcontrib>LARUSSA, Philip S</creatorcontrib><creatorcontrib>MARCY, S. Michael</creatorcontrib><creatorcontrib>FULGINITI, Vincent A</creatorcontrib><creatorcontrib>MARTIN, Bryan</creatorcontrib><creatorcontrib>MCMAHON, Ann</creatorcontrib><creatorcontrib>NORTON, Scott A</creatorcontrib><creatorcontrib>TROLIN, Ingrid</creatorcontrib><title>Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic</title><title>Vaccine</title><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Virology</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNUc1uEzEQXlCRCIV3mAtSkRyxm6SQ9gZNERwqIcGBWzWxZ3eNvLblsbfdPncfgElTCdITJ8vj79fzvJo164_L-eK0WR9Vs3rxYTVfNfWvl9Ur5t91XZ8um7PZs_vvKXSJmO1IMKLW1lsEZEAPaEZKTEAj-QxtcC7cWN8B3cbAJRHk8Jcy2lQYzuEChWGolWG2QUS8ga5YQ856YggtGMwIWtRI7xBKIOgmtqwewFHSiB8-sAVuh6F4e7e_M7aUp73EOXxOtuuzjHdquA3pEZRFB5Oxd2RAH-bhp4HakA6L8j9ND7xPJGfsJ4e3u6jkNcUenajy-0-byytJzxSz1TCQF_LuQUEr3K6QgiJm0aF4GuBiDHlJhbmHk823zY93ChJyryD3KQzboKccosigAk3OFbdXwy1r2ZUC603Zt1XAN4IQQ_V0GYe1FPRTDPJbVr-uXrTomN48nsfV2y-XPy--ziOyRtcm9NrydUx2wDRdN-uzVbNcrJb_i_sDRfHfig</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>NELL, Patricia</creator><creator>KOHL, Katrin S</creator><creator>GRAHAM, Philip L</creator><creator>LARUSSA, Philip S</creator><creator>MARCY, S. Michael</creator><creator>FULGINITI, Vincent A</creator><creator>MARTIN, Bryan</creator><creator>MCMAHON, Ann</creator><creator>NORTON, Scott A</creator><creator>TROLIN, Ingrid</creator><general>Elsevier</general><scope>IQODW</scope></search><sort><creationdate>2007</creationdate><title>Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic</title><author>NELL, Patricia ; KOHL, Katrin S ; GRAHAM, Philip L ; LARUSSA, Philip S ; MARCY, S. Michael ; FULGINITI, Vincent A ; MARTIN, Bryan ; MCMAHON, Ann ; NORTON, Scott A ; TROLIN, Ingrid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_189413243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NELL, Patricia</creatorcontrib><creatorcontrib>KOHL, Katrin S</creatorcontrib><creatorcontrib>GRAHAM, Philip L</creatorcontrib><creatorcontrib>LARUSSA, Philip S</creatorcontrib><creatorcontrib>MARCY, S. Michael</creatorcontrib><creatorcontrib>FULGINITI, Vincent A</creatorcontrib><creatorcontrib>MARTIN, Bryan</creatorcontrib><creatorcontrib>MCMAHON, Ann</creatorcontrib><creatorcontrib>NORTON, Scott A</creatorcontrib><creatorcontrib>TROLIN, Ingrid</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NELL, Patricia</au><au>KOHL, Katrin S</au><au>GRAHAM, Philip L</au><au>LARUSSA, Philip S</au><au>MARCY, S. Michael</au><au>FULGINITI, Vincent A</au><au>MARTIN, Bryan</au><au>MCMAHON, Ann</au><au>NORTON, Scott A</au><au>TROLIN, Ingrid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic</atitle><jtitle>Vaccine</jtitle><date>2007</date><risdate>2007</risdate><volume>25</volume><issue>31</issue><spage>5735</spage><epage>5744</epage><pages>5735-5744</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><cop>Oxford</cop><pub>Elsevier</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2007, Vol.25 (31), p.5735-5744 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_pascalfrancis_primary_18941324 |
source | Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
subjects | Applied microbiology Biological and medical sciences Fundamental and applied biological sciences. Psychology Microbiology Miscellaneous Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Virology |
title | Progressive vaccinia as an adverse event following exposure to vaccinia virus : Case definition and guidelines of data collection, analysis, and presentation of immunization safety data : Brighton collaboration standardized case definitions and guidelines for adverse events following immunization (anaphylaxis, encephalitis/ADEM, aseptic meningitis, fatigue, unesplained sudden death (DIDS), rash, thrombocytopenia, cellulitis, abscess, induration, swelling, vaccinia virus adverse events, hypotonic |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T22%3A04%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progressive%20vaccinia%20as%20an%20adverse%20event%20following%20exposure%20to%20vaccinia%20virus%20:%20Case%20definition%20and%20guidelines%20of%20data%20collection,%20analysis,%20and%20presentation%20of%20immunization%20safety%20data%20:%20Brighton%20collaboration%20standardized%20case%20definitions%20and%20guidelines%20for%20adverse%20events%20following%20immunization%20(anaphylaxis,%20encephalitis/ADEM,%20aseptic%20meningitis,%20fatigue,%20unesplained%20sudden%20death%20(DIDS),%20rash,%20thrombocytopenia,%20cellulitis,%20abscess,%20induration,%20swelling,%20vaccinia%20virus%20adverse%20events,%20hypotonic&rft.jtitle=Vaccine&rft.au=NELL,%20Patricia&rft.date=2007&rft.volume=25&rft.issue=31&rft.spage=5735&rft.epage=5744&rft.pages=5735-5744&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E18941324%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |